Invention Grant
- Patent Title: Thienopyrimidone compound
- Patent Title (中): 噻吩并嘧啶酮化合物
-
Application No.: US11919301Application Date: 2006-04-27
-
Publication No.: US07989445B2Publication Date: 2011-08-02
- Inventor: Toshiki Murata , Shingo Makino
- Applicant: Toshiki Murata , Shingo Makino
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Edwards Angell Palmer & Dodge LLP
- Agent David G. Conlin; Dwight D. Kim
- Priority: JP2005-132652 20050428
- International Application: PCT/JP2006/309201 WO 20060427
- International Announcement: WO2006/118320 WO 20061109
- Main IPC: A61K31/55
- IPC: A61K31/55 ; A61K31/519 ; A61P3/04 ; C07D495/04

Abstract:
The present invention relates to a compound represented by the formula: wherein Ar is an optionally substituted ring; A is a spacer having a main chain of 1 to 4 atoms; B is a bond, a C1-10 alkylene group or an oxygen atom; R3 and R5 are each independently a hydrogen atom or a substituent; R4 is an optionally substituted cyclic group or an optionally substituted C1-10 alkyl group; and R1 and R2 are each independently a hydrogen atom or a substituent, or R1 and R2 or R1 and B are bonded to form an optionally substituted nitrogen-containing heterocycle, or R1 and Ar are bonded to form an optionally substituted nitrogen-containing fused heterocycle, or a salt thereof. The thienopyrimidone compound of the present invention has a superior melanin-concentrating hormone receptor antagonistic action, and is useful as an agent for the prophylaxis or treatment of obesity and the like.
Public/Granted literature
- US20100069362A1 Thienopyrimidone compound Public/Granted day:2010-03-18
Information query